Search alternatives:
large decrease » marked decrease (Expand Search), large increases (Expand Search), large degree (Expand Search)
n marked » _ marked (Expand Search), _ market (Expand Search), _ marker (Expand Search)
a marked » _ marked (Expand Search), a market (Expand Search), _ market (Expand Search)
a marker » _ marker (Expand Search), _ markers (Expand Search)
b large » _ large (Expand Search), a large (Expand Search), i large (Expand Search)
increase » increased (Expand Search)
large decrease » marked decrease (Expand Search), large increases (Expand Search), large degree (Expand Search)
n marked » _ marked (Expand Search), _ market (Expand Search), _ marker (Expand Search)
a marked » _ marked (Expand Search), a market (Expand Search), _ market (Expand Search)
a marker » _ marker (Expand Search), _ markers (Expand Search)
b large » _ large (Expand Search), a large (Expand Search), i large (Expand Search)
increase » increased (Expand Search)
-
1
-
2
-
3
-
4
-
5
-
6
-
7
-
8
-
9
-
10
-
11
-
12
Deletion of Hhp2 markedly increased Sre1 activity.
Published 2020“…<p>Deletion of <i>hhp2</i><sup>+</sup> gene markedly increased Sre1 activity in the presence/absence of CLZ (2 μg/ml to 8 μg/ml) (A), TER (2 μg/ml to 8 μg/ml) (B) or CoCl<sub>2</sub> (0.08 mM to 0.32 mM) (C). …”
-
13
Simplified scheme illustrating the inhibitory effect of nNOS on the PPP during the initiation of GSIS.
Published 2025“…<p>1) A marked increase in glucose concentration results in a large accumulation of the released insulin at the exocytotic sites of nNOS-associated insulin granules (denoted as orange circles on insulin granules) in the PPP. …”
-
14
-
15
-
16
Evogliptin attenuates the pyroptotic cell death of VSMCs during CER treatment by decreasing the pyroptotic-associated genes and GSDM-D cleavage efficiency <i>in-vitro.</i>
Published 2025“…<p>(A) Bar graph showed EVO significantly decreased Lactate dehydrogenase (LDH) release in CER treated P<sub>i</sub>‐induced VSMCs. …”
-
17
-
18
-
19
-
20